Allogeneic Hematopoietic Cell Transplantation (alloHCT) for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 (MLL/AF4) B-Acute Lymphoblastic Leukemia in first complete remission (CR1): favorable outcome of patients with negative Minimal Residual Disease (MRD) status at transplant. A report from the Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation (ALWP-EBMT)

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Jordi Esteve, Myriam Labopin, Tomasz Czerw, Depei Wu, Liisa Volin, Gérard Socié, Jean-Pierre Jouet, Johan Maertens, Jan J Cornelissen, Arnaud Pigneux, Avichai Shimoni, Rainer Schwerdtfeger, Mauricette Michallet, Nigel H. Russell, Patrice Chevallier, Antonius VMB Schattenberg, Vladimir Koza, Robin Foa, Christoph SchmidORCiDGND, Sebastian Giebel, Mohamad Mohty, Arnon Nagler
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/98419
URL:https://ashpublications.org/blood/article/130/Suppl_1/669/83270/Allogeneic-Hematopoietic-Cell-Transplantation
ISSN:0006-4971OPAC
ISSN:1528-0020OPAC
Parent Title (English):Blood
Publisher:American Society of Hematology
Place of publication:Washington, DC
Type:Article
Language:English
Year of first Publication:2017
Release Date:2022/10/07
Tag:Cell Biology; Hematology; Immunology; Biochemistry
Volume:130
Issue:Supplement 1
First Page:669
DOI:https://doi.org/10.1182/blood.v130.suppl_1.669.669
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Innere Medizin mit Schwerpunkt Hämatologie und Onkologie
Medizinische Fakultät / Professur für Transplantation und Zelltherapieforschung